• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Alzheimer’s disease - Articles and news items

Amarantus forms Elto Pharma for CNS Disorders and MANF Therapeutics for Ophthalmology

Industry news / 18 April 2017 / Niamh Marriott, Junior Editor

Amarantus Bioscience has formed a wholly-owned subsidiary named Elto Pharma for the purpose of creating investment vehicles focused exclusively on the further development of Eltoprazine, Amarantus’ mid-stage central nervous system (CNS) symptomatic treatment for Adult Attention Deficit and Hyperactivity Disorder (Adult ADHD), Alzheimer’s Aggression and Parkinson’s disease Levodopa-induced Dyskinesia (PD-LID). Concurrently, Amarantus has formed the […]

Trial uses herpes drugs to slow down Alzheimer’s disease

Industry news / 20 December 2016 / Niamh Louise Marriott, Digital Editor

The first clinical study to investigate if herpes virus drugs can have an effect on fundamental Alzheimer’s disease processes has been launched…

Alzheimer’s disease: reviewing the immediate treatment horizon

Blog, Z Homepage promo / 5 September 2016 / Stuart Goodman, Blue Latitude Health

Blue Latitude Health’s Stuart Goodman discusses the latest progress in Alzheimer’s disease research and treatment to find out why a cure remains elusive…